Clinical Trial Update: Safety and Value of Self Bone Marrow Transplants Following Chemotherapy in Scleroderma Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety and potential value of autologous bone marrow transplants after chemotherapy in patients with systemic sclerosis; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Conditions: Scleroderma, Systemic Sclerosis | Phase 1 | Status: TERMINATED